Metformin for endothelial dysfunction in non-diabetic disorders: a scoping review.

BMJ Open · 2025 · PMC12506206 · PMID 41057192

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Metformin showed a trend towards improvement for 7/19 (36.8%) biomarkers.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.